|
Age (years)
|
71.0 (10.3)
|
71.0 (10.7)
|
0.99
|
|
Gender (% male (N))
|
95.9% (401)
|
94.5% (343)
|
0.34
|
|
Race (% black (N))
|
45.9% (192)
|
44.9% (163)
|
0.77
|
|
Past Medical History (% (N))
| | | |
|
Diabetes
|
50.2% (210)
|
44.9% (163)
|
0.14
|
|
Hypertension
|
93.1% (389)
|
97.0% (352)
|
0.013
|
|
Coronary artery disease
|
31.6% (132)
|
40.8% (148)
|
0.008
|
|
Cancer
|
21.1% (88)
|
21.8% (79)
|
0.81
|
|
Last systolic BP (mmHg)
|
133.1 (18.4)
|
132.4 (17.9)
|
0.63
|
|
Last diastolic BP (mmHg)
|
72.8 (11.7)
|
71.6 (12.2)
|
0.17
|
|
Renal function
| | | |
|
Average eGFR during study period*
|
47.8 (40, 56)
|
48.1 (39, 55)
|
0.40
|
|
Stage of CKD (%)
| | | |
|
III
|
91.6%
|
89.5%
|
0.52
|
|
IV
|
7.7%
|
9.9%
| |
|
V
|
0.7%
|
0.6%
| |
|
Proteinuria
|
24.2%
|
20.7%
|
0.24
|
|
Most recent laboratory results
| | | |
|
PTH*
|
104 (61, 184)
|
95 (62, 156)
|
0.74
|
|
Phosphorus
|
3.7 (0.7)
|
3.7 (0.7)
|
0.54
|
|
Hemoglobin
|
12.8 (1.9)
|
12.6 (1.8)
|
0.35
|
|
Number of clinic visits during study period
|
2.4 (1.4)
|
2.3 (1.4)
|
0.30
|
|
Seen by nephrology during the study period
|
16.3%
|
19.8%
|
0.19
|
|
Seen in urgent care during the study period
|
49.8%
|
52.9%
|
0.38
|
